{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:45:17Z","timestamp":1782913517555,"version":"3.54.5"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtauto.2025.100331","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:59:07Z","timestamp":1762617547000},"page":"100331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Emerging cell-based and cell-free therapeutic strategies for vitiligo"],"prefix":"10.1016","volume":"11","author":[{"given":"Nasser","family":"Gholijani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effat","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Zarei-Behjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delsuz","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khodaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamhossien","family":"Darya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra","family":"Mehdinejadiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-1287","authenticated-orcid":false,"given":"Zeinab","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment. Cell Res."},{"key":"10.1016\/j.jtauto.2025.100331_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2025.100331_bib3","article-title":"Recent trends in the treatment of vitiligo using novel drug delivery system","author":"Sahu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100331_bib4","article-title":"Unveiling the unseen struggles: a comprehensive review of Vitiligo's psychological, social, and quality of life impacts","volume":"15","author":"Salama","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtauto.2025.100331_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1072837","article-title":"Beyond skin white spots: vitiligo and associated comorbidities","volume":"10","author":"Hu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jtauto.2025.100331_bib6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pcmr.12974","article-title":"Vitiligo: translational research and effective therapeutic strategies","volume":"34","author":"Thakur","year":"2021","journal-title":"Pigment Cell & Melanoma Research"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13215","article-title":"Therapeutic options in vitiligo with special emphasis on immunomodulators: a comprehensive update with review of literature","volume":"33","author":"Agarwal","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2010.10.043","article-title":"Vitiligo: a comprehensive overview: part II: treatment options and approach to treatment","volume":"65","author":"Felsten","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100331_bib9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/1346-8138.16028","article-title":"Cultured epidermal autografts for treatment of stable vitiligo: quantitative analysis of color matching with surrounding normally pigmented skin","volume":"48","author":"Toriyama","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100331_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4103\/0378-6323.102362","article-title":"A descriptive study to characterize segmental vitiligo","volume":"78","author":"Khaitan","year":"2012","journal-title":"Indian J. Dermatol., Venereol. Leprol."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/jid.2015.92","article-title":"A new view of vitiligo: looking at normal-appearing skin","volume":"135","author":"Picardo","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100331_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101766","article-title":"Vitiligo: an immune disease and its emerging mesenchymal stem cell therapy paradigm","volume":"76","author":"Zhang","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.jtauto.2025.100331_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105832","article-title":"Exosomes as a roadmap from research to clinical development in the management OF SKIN diseases","author":"Mane","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jtauto.2025.100331_bib14","article-title":"Strategies to optimize adult stem cell therapy for tissue regeneration","volume":"17","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib15","article-title":"Enhancing regenerative medicine: the crucial role of stem cell therapy","volume":"18","author":"Wang","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jtauto.2025.100331_bib16","series-title":"Annual Review of Immunology","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","author":"Frisoli","year":"2020"},{"key":"10.1016\/j.jtauto.2025.100331_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14 1","author":"Dwivedi","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100331_bib18","article-title":"Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo: a review","author":"Esquive","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib19","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/ajt.17001","article-title":"Mesenchymal stem cells augment regulatory T cell function via CD80-mediated interactions and promote allograft survival","volume":"22","author":"Mittal","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jtauto.2025.100331_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcell.2013.00002","article-title":"Grand challenges in stem cell treatments","volume":"1","author":"Ikehara","year":"2013","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jtauto.2025.100331_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102664","article-title":"New insight into the role of exosomes in vitiligo","author":"Wong","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100331_bib23","article-title":"Exosome-derived microRNAs: emerging players in vitiligo","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100331_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.18942","article-title":"A study of autologous melanocyte transfer in treatment of stable vitiligo","volume":"71","author":"Pandya","year":"2005","journal-title":"Indian J. Dermatol., Venereol. Leprol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mjafi.2013.09.004","article-title":"A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo","volume":"70","author":"Verma","year":"2014","journal-title":"Med. J. Armed Forces India"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.abd.2021.08.003","article-title":"Treatment of recalcitrant vitiligo by autologous non-cultured and trypsinized melanocyte grafting in the west of Iran","volume":"97","author":"Ghorbani","year":"2022","journal-title":"An. Bras. Dermatol."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040377","article-title":"Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach","volume":"7","author":"Thingnes","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1346-8138.2000.tb02201.x","article-title":"Transplant of cultured autologous pure melanocytes after laser\u2010abrasion for the treatment of segmental vitiligo","volume":"27","author":"Chen","year":"2000","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1684\/ejd.2024.4602","article-title":"The regenerative potential of autologous stem and somatic cells in vitiligo","volume":"34","author":"Chanteloube","year":"2024","journal-title":"Eur. J. Dermatol. : EJD"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/pcmr.12600","article-title":"The first transepidermal transplantation of non\u2010cultured epidermal suspension using a dermarolling system in vitiligo: a sequential histological and clinical study","volume":"30","author":"Benzekri","year":"2017","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib31","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/ijms24043357","article-title":"Current status of cell-based therapies for vitiligo","volume":"24","author":"Domaszewska-Szostek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/etm.2016.3949","article-title":"Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo","volume":"13","author":"Zhu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060254","article-title":"Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2133.2002.04837.x","article-title":"Long\u2010term follow\u2010up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension","volume":"147","author":"Olsson","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1365-2133.2011.10234.x","article-title":"Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo","volume":"164","author":"Mohanty","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jdv.12426","article-title":"Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non\u2010cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo","volume":"29","author":"Vinay","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jtauto.2025.100331_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/ijdvl.IJDVL_261_18","article-title":"Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo","volume":"86","author":"Shi","year":"2020","journal-title":"Indian J. Dermatol., Venereol. Leprol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/JCAS.JCAS_189_19","article-title":"A comparative study between follicular unit transplantation and autologous non-cultured non-trypsinized epidermal cells grafting (Jodhpur technique) in stable vitiligo","volume":"13","author":"Lamoria","year":"2020","journal-title":"J. Cutan. Aesthetic Surg."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ijd.13895","article-title":"Efficacy and safety of noncultured melanocyte\u2010keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence","volume":"57","author":"Vakharia","year":"2018","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/jocd.12759","article-title":"The effect of NB\u2010UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor\u2010to\u2010recipient ratios","volume":"18","author":"Tawfik","year":"2019","journal-title":"J. Cosmet. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0190-9622(92)70024-A","article-title":"Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions","volume":"26","author":"Gauthier","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jaad.2011.05.002","article-title":"Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States","volume":"66","author":"Huggins","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/DSS.0000000000003738","article-title":"Dermabrasion versus microneedling in transplantation of autologous noncultured melanocyte\u2013keratinocyte cell suspension in patients with vitiligo","volume":"49","author":"Hasan","year":"2023","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jtauto.2025.100331_bib44","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2147\/CCID.S485421","article-title":"Sustained repigmentation in vitiligo and leukodermas using Melanocyte\u2013Keratinocyte transplantation: 7 years of data","author":"Nuntawisuttiwong","year":"2024","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib45","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/jocd.14324","article-title":"Fractional versus full ablative CO2 laser in recipient site of non\u2010cultured melanocytes and keratinocyte transplantation in treatment of vitiligo","volume":"21","author":"Jamal\u2010edine","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100331_bib46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib47","article-title":"An update on the potential of mesenchymal stem cell therapy for cutaneous diseases","volume":"2021","author":"Li","year":"2021","journal-title":"Stem Cell. Int."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib48","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s12015-022-10328-w","article-title":"Research update of adipose tissue-based therapies in regenerative dermatology","volume":"18","author":"Bellei","year":"2022","journal-title":"Stem Cell Rev Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biomedicines7020027","article-title":"Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. biomolecular pathway analysis and clinical evaluation","volume":"7","author":"Gentile","year":"2019","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib50","doi-asserted-by":"crossref","DOI":"10.18295\/squmj.2018.18.03.002","article-title":"Sources and clinical applications of mesenchymal stem cells: state-of-the-art review","volume":"18","author":"Berebichez-Fridman","year":"2018","journal-title":"Sultan Qaboos Univ. Med. J."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep37801","article-title":"Adipose stem cells display higher regenerative capacities and more adaptable electro-kinetic properties compared to bone marrow-derived mesenchymal stromal cells","volume":"6","author":"El-Badawy","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.tcb.2020.09.007","article-title":"Toward a consensus view of mammalian adipocyte stem and progenitor cell heterogeneity","volume":"30","author":"Ferrero","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib53","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/biomedicines10112744","article-title":"Regenerative medicine-based treatment for vitiligo: an overview","volume":"10","author":"Bellei","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10710-6","article-title":"Maximizing non-enzymatic methods for harvesting adipose-derived stem from lipoaspirate: technical considerations and clinical implications for regenerative surgery","volume":"7","author":"Bellei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2025.100331_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1364-0","article-title":"Differentiation of adipose-derived stem cells to functional CD105 neg CD73 low melanocyte precursors guided by defined culture condition","volume":"10","author":"Zavala","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100331_bib56","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3390\/ijms19082200","article-title":"Revisiting the advances in isolation, characterization and secretome of adipose-derived stromal\/stem cells","volume":"19","author":"Dubey","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02265-1","article-title":"Mesenchymal stem\/stromal cells as a valuable source for the treatment of immune-mediated disorders","volume":"12","author":"Markov","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/exd.13954","article-title":"Extracellular fraction of adipose tissue as an innovative regenerative approach for vitiligo treatment","volume":"28","author":"Bellei","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"37","key":"10.1016\/j.jtauto.2025.100331_bib59","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.2174\/1381612826666200730221446","article-title":"Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo: a review","volume":"26","author":"Esquivel","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8+ T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib61","doi-asserted-by":"crossref","first-page":"E512","DOI":"10.1152\/ajpendo.00341.2020","article-title":"Visceral adipose tissue mesenchymal stromal cells in the intersection of immunology and metabolism","volume":"320","author":"Spallanzani","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jid.2014.309","article-title":"CD90+ human dermal stromal cells are potent inducers of FoxP3+ regulatory T cells","volume":"135","author":"Pfisterer","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib63","article-title":"Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes","volume":"92","author":"Kim","year":"2012","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4062\/biomolther.2014.065","article-title":"Adipose-derived stem cells improve efficacy of melanocyte transplantation in animal skin","volume":"22","author":"Lim","year":"2014","journal-title":"Biomol Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/ijms21010049","article-title":"Conditioned medium from human adipose-derived mesenchymal stem cell culture prevents UVB-induced skin aging in human keratinocytes and dermal fibroblasts","volume":"21","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0956-4","article-title":"Adipose tissue-derived extracellular fraction characterization: biological and clinical considerations in regenerative medicine","volume":"9","author":"Bellei","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100331_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256622","article-title":"Melanocyte progenitor cells reside in human subcutaneous adipose tissue","volume":"16","author":"Ikeda","year":"2021","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.jtauto.2025.100331_bib68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.9734\/jammr\/2022\/v34i234890","article-title":"Adipose derived stem cells in the treatment of vitiligo","volume":"34","author":"Fahmy","year":"2022","journal-title":"J. Adv. Med. Med. Res."},{"key":"10.1016\/j.jtauto.2025.100331_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-017-0674-3","article-title":"Pluripotent nontumorigenic multilineage differentiating stress enduring cells (Muse cells): a seven-year retrospective","volume":"8","author":"Fisch","year":"2017","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100331_bib70","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/jid.2013.172","article-title":"Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts","volume":"133","author":"Tsuchiyama","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib71","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jid.2017.06.021","article-title":"The potential of muse cells for regenerative medicine of skin: procedures to reconstitute skin with muse cell-derived keratinocytes, fibroblasts, and melanocytes","volume":"137","author":"Yamauchi","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib72","first-page":"116","article-title":"Muse cells derived from dermal tissues can differentiate into melanocytes, Cellular reprogramming","volume":"19","author":"Tian","year":"2017","journal-title":"Formerly\" Cloning and Stem Cells\")"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13287-025-04410-6","article-title":"Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo","volume":"16","author":"Fan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jtauto.2025.100331_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1583271","article-title":"Injectable crosslinked HA hydrogel: a promising carrier for cell transplantation to treat stable vitiligo","volume":"12","author":"Zheng","year":"2025","journal-title":"Front. Med."},{"issue":"17","key":"10.1016\/j.jtauto.2025.100331_bib75","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2025.100331_bib76","article-title":"Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2025.100331_bib77","series-title":"Osteochondral Tissue Engineering: Challenges, Current Strategies, and Technological Advances","first-page":"241","author":"Cengiz","year":"2018"},{"issue":"8","key":"10.1016\/j.jtauto.2025.100331_bib78","first-page":"28","article-title":"Progress in the use of platelet-rich plasma in aesthetic and medical dermatology","volume":"13","author":"Lin","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol"},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib79","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/exd.14532","article-title":"Therapeutic potential of adipose tissue\u2010derivatives in modern dermatology","volume":"31","author":"Bellei","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib80","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.arthro.2014.02.020","article-title":"Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model","volume":"30","author":"Magalon","year":"2014","journal-title":"Arthrosc. J. Arthrosc. Relat. Surg."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib81","first-page":"32","article-title":"Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts","volume":"29","author":"Cho","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib82","first-page":"6","article-title":"Platlet rich plasma (PRP) improves fat grafting outcomes","volume":"2","author":"Modarressi","year":"2013","journal-title":"World J. Plast. Surg."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib83","doi-asserted-by":"crossref","first-page":"550","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20183464","article-title":"Effect of intralesional platelet rich plasma in chronic localized vitiligo","volume":"4","author":"Mahajan","year":"2018","journal-title":"Int J Res Dermatol"},{"key":"10.1016\/j.jtauto.2025.100331_bib84","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2147\/CCID.S178817","article-title":"Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study","author":"Kadry","year":"2018","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib85","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jocd.12194","article-title":"The effect of platelet\u2010rich plasma on the outcome of short\u2010term narrowband\u2013ultraviolet B phototherapy in the treatment of vitiligo: a pilot study","volume":"15","author":"Ibrahim","year":"2016","journal-title":"J. Cosmet. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib86","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jocd.12397","article-title":"Combined treatment with fractional carbon dioxide laser, autologous platelet\u2010rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial","volume":"17","author":"Abdelghani","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib87","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ijd.14286","article-title":"Use of platelet\u2010rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double\u2010blind randomized controlled trial","volume":"58","author":"Parambath","year":"2019","journal-title":"Int. J. Dermatol."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100331_bib88","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221119646","article-title":"Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo","volume":"50","author":"Chen","year":"2022","journal-title":"J. Int. Med. Res."},{"issue":"9","key":"10.1016\/j.jtauto.2025.100331_bib89","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib90","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jid.2017.09.040","article-title":"Repigmentation of human vitiligo skin by NBUVB is controlled by transcription of GLI1 and activation of the \u03b2-catenin pathway in the hair follicle bulge stem cells","volume":"138","author":"Goldstein","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib92","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib93","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib94","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12964-023-01227-9","article-title":"Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction","volume":"21","author":"Liu","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"6478","key":"10.1016\/j.jtauto.2025.100331_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"science"},{"issue":"15","key":"10.1016\/j.jtauto.2025.100331_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103222","article-title":"Exosome processing and characterization approaches for research and technology development","volume":"9","author":"Lai","year":"2022","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib97","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/IAI.06014-11","article-title":"Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life","volume":"80","author":"Deatherage","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jtauto.2025.100331_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103565","article-title":"Emerging role of exosomes as biomarkers in cancer treatment and diagnosis","volume":"169","author":"Hanjani","year":"2022","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib99","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.3390\/ijms23116273","article-title":"Molecular insight into the therapeutic effects of stem cell-derived exosomes in respiratory diseases and the potential for pulmonary delivery","volume":"23","author":"Azhdari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib101","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/cancers13051157","article-title":"Expedition into exosome biology: a perspective of progress from discovery to therapeutic development","volume":"13","author":"Jan","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib102","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/cancers13040822","article-title":"Exosomes and cell communication: from tumour-derived exosomes and their role in tumour progression to the use of exosomal cargo for cancer treatment","volume":"13","author":"Nicolini","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.jtauto.2025.100331_bib103","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib104","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11033-024-09282-2","article-title":"Exosomes as modulators of embryo implantation","volume":"51","author":"Dehghan","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jtauto.2025.100331_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130728","article-title":"Exosome-mediated delivery and regulation in neurological disease progression","volume":"264","author":"Singh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib106","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1039\/D0NR07622H","article-title":"Exosome-mediated delivery of gene vectors for gene therapy","volume":"13","author":"Duan","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib107","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12943-019-0980-8","article-title":"Extracellular vesicles in the tumor microenvironment: old stories, but new tales","volume":"18","author":"Han","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jtauto.2025.100331_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105680","article-title":"The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes","volume":"169","author":"Miao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jtauto.2025.100331_bib109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib110","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib111","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","article-title":"Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms","volume":"29","author":"Dad","year":"2021","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102664","article-title":"New insight into the role of exosomes in vitiligo","volume":"19","author":"Wong","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100331_bib113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2025.100331_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866703","article-title":"Networks of CD8+ T cell response activation in melanoma and vitiligo","volume":"13","author":"Fukuda","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib115","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100331_bib116","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1468-3083.2008.02681.x","article-title":"Evaluation of activatory and inhibitory natural killer cell receptors in non\u2010segmental vitiligo: a flow cytometric study","volume":"22","author":"Basak","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdermsci.2023.12.006","article-title":"Exosomes containing miR-1469 regulate natural killer cells by targeting CD122 in non-segmental vitiligo","volume":"113","author":"Wei","year":"2024","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib118","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clicom.2022.08.002","article-title":"Identification and functional analysis of exosomal miR-16-5p, miR-6721-5p, and miR-486-5p associated with immune infiltration for potential vitiligo theranostics","volume":"2","author":"Thakur","year":"2022","journal-title":"Clin Immunol Commun."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib119","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.jid.2022.05.1086","article-title":"Circulating exosomal miR-493-3p affects melanocyte survival and function by regulating epidermal dopamine concentration in segmental vitiligo","volume":"142","author":"Li","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.15171\/apb.2016.041","article-title":"Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy","volume":"6","author":"Sarvar","year":"2016","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.jtauto.2025.100331_bib121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fvets.2017.00039","article-title":"Mesenchymal stem cell-derived exosomes: immunomodulatory evaluation in an antigen-induced synovitis porcine model","volume":"4","author":"Casado","year":"2017","journal-title":"Front. Vet. Sci."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib122","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.7150\/thno.21072","article-title":"Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis","volume":"8","author":"Cosenza","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jtauto.2025.100331_bib123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2017.11.008","article-title":"BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis","volume":"93","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"issue":"15","key":"10.1016\/j.jtauto.2025.100331_bib124","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1158\/0008-5472.CAN-06-3456","article-title":"Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2","volume":"67","author":"Clayton","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib125","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib126","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.176.3.1375","article-title":"Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function","volume":"176","author":"Liu","year":"2006","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib127","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.4049\/jimmunol.178.11.6867","article-title":"Tumor exosomes inhibit differentiation of bone marrow dendritic cells","volume":"178","author":"Yu","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.180.2.817","article-title":"Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells","volume":"180","author":"Eken","year":"2008","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.jtauto.2025.100331_bib129","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.7150\/thno.56367","article-title":"Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia","volume":"11","author":"Tian","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells8121605","article-title":"Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases","volume":"8","author":"Harrell","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jtauto.2025.100331_bib131","first-page":"1333","volume":"7","author":"Bellavia","year":"2017","journal-title":"Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib132","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jdermsci.2020.03.002","article-title":"585 nm light-emitting diodes inhibit melanogenesis through upregulating H19\/miR-675 axis in LEDs-irradiated keratinocytes by paracrine effect","volume":"98","author":"Jin","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100331_bib133","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1111\/jocd.14762","article-title":"Role of miRNAs in melanin metabolism: implications in melanin\u2010related diseases","volume":"21","author":"Zhang","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib134","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1038\/ncomms8506","article-title":"Exosomes released by keratinocytes modulate melanocyte pigmentation","volume":"6","author":"Cicero","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jtauto.2025.100331_bib135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/1346-8138.15202","article-title":"Quantitative changes in the secretion of exosomes from keratinocytes homeostatically regulate skin pigmentation in a paracrine manner","volume":"47","author":"Takano","year":"2020","journal-title":"J. Dermatol."},{"issue":"20","key":"10.1016\/j.jtauto.2025.100331_bib136","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1111\/jcmm.15864","article-title":"Down\u2010regulation of exosomal miR\u2010200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"31","key":"10.1016\/j.jtauto.2025.100331_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404064","article-title":"3D\u2010hUMSCs exosomes ameliorate vitiligo by simultaneously potentiating treg cells\u2010mediated immunosuppression and suppressing oxidative stress\u2010induced melanocyte damage","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib138","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/1346-8138.17320","article-title":"Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: a retrospective study","volume":"51","author":"Lin","year":"2024","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100331_bib139","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1159\/000533353","article-title":"Safety and efficacy of autologous Melanocyte\/Keratinocyte transplantation in patients with refractory stable vitiligo","volume":"239","author":"Shahbazi","year":"2023","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib140","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archderm.134.12.1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jtauto.2025.100331_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092508","article-title":"Insights into differentiation of melanocytes from human stem cells and their relevance for Melanoma treatment","volume":"12","author":"Mirea","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jtauto.2025.100331_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076398","article-title":"Generating functional and highly proliferative melanocytes derived from human pluripotent stem cells: a promising tool for biotherapeutic approaches to treat skin pigmentation disorders","volume":"24","author":"Saidani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib143","article-title":"Microneedle-based technology for cell therapy: current status and future directions","author":"Chen","year":"2022","journal-title":"Nanoscale Horiz."},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib144","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/acsabm.0c00498","article-title":"Solid composite material for delivering viable cells into skin tissues via detachable dissolvable microneedles","volume":"3","author":"Pukfukdee","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jtauto.2025.100331_bib145","first-page":"126","article-title":"Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade","volume":"36","author":"Moghassemi","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jtauto.2025.100331_bib146","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jtauto.2025.100331_bib147","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3634563","article-title":"A comparison of traditional and novel methods for the separation of exosomes from human samples","volume":"2018","author":"Yu","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib148","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/cosmetics11050154","article-title":"Medicalized aesthetic uses of exosomes and cell culture-conditioned media: opening an advanced care era for biologically inspired cutaneous prejuvenation and rejuvenation","volume":"11","author":"Rodriguez","year":"2024","journal-title":"Cosmetics"},{"issue":"7","key":"10.1016\/j.jtauto.2025.100331_bib149","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ymthe.2018.04.024","article-title":"Exosomes in myocardial repair: advances and challenges in the development of next-generation therapeutics","volume":"26","author":"Adamiak","year":"2018","journal-title":"Mol. Ther."},{"issue":"22","key":"10.1016\/j.jtauto.2025.100331_bib150","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1113\/JP282053","article-title":"Challenges and future scope of exosomes in the treatment of cardiovascular diseases","volume":"601","author":"Ranjan","year":"2023","journal-title":"J Physiol."},{"issue":"10","key":"10.1016\/j.jtauto.2025.100331_bib151","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s13346-021-01087-1","article-title":"Exosomal targeting and its potential clinical application","volume":"12","author":"He","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib152","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdermsci.2017.10.007","article-title":"A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: a 30-month follow-up","volume":"89","author":"Orouji","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib153","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0974-7753.188042","article-title":"A study of noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo","volume":"8","author":"Shah","year":"2016","journal-title":"Int. J. Trichol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib154","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/ijd.13759","article-title":"Study of efficacy and safety of noncultured, extracted follicular outer root sheath cell suspension transplantation in the management of stable vitiligo","volume":"57","author":"Kumar","year":"2018","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2017.01.056","article-title":"Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas","volume":"77","author":"Silpa-Archa","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib156","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/jdv.15411","article-title":"Six\u2010year follow\u2010up of vitiligo patients successfully treated with autologous non\u2010cultured melanocyte\u2013keratinocyte transplantation","volume":"33","author":"Altalhab","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.jtauto.2025.100331_bib157","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jfma.2023.12.005","article-title":"Melanocyte transplantation to skin prepared by controlled PUVA-induced sunburn-like blistering for vitiligo treatment\u2013A pilot clinical trial","volume":"123","author":"Chen","year":"2024","journal-title":"J. Formos. Med. Assoc."},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib158","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1159\/000533353","article-title":"Safety and efficacy of autologous melanocyte\/keratinocyte transplantation in patients with refractory stable vitiligo","volume":"239","author":"Shahbazi","year":"2023","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jtauto.2025.100331_bib159","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14362","article-title":"Autologous noncultured, nontrypsinized melanocyte\u2010keratinocyte graft homogenized in plasma gel followed by narrow\u2010band ultraviolet B therapy for stable vitiligo: a novel technique","volume":"33","author":"Elgarhy","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jtauto.2025.100331_bib160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/ijdvl.IJDVL_1130_16","article-title":"Autologous noncultured melanocyte-keratinocyte transplantation in stable vitiligo: a randomized comparative study of recipient site preparation by two techniques","volume":"85","author":"Gupta","year":"2019","journal-title":"Indian J. Dermatol., Venereol. Leprol."},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib161","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamadermatol.2018.4919","article-title":"Efficacy of transplantation of combination of noncultured dermal and epidermal cell suspension vs epidermal cell suspension alone in vitiligo: a randomized clinical trial","volume":"155","author":"Thakur","year":"2019","journal-title":"JAMA dermatology"},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib162","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/DSS.0000000000004320","article-title":"Impact of combined phototherapy and melanocyte transplantation on indicators of vitiligo activity","volume":"50","author":"Wang","year":"2024","journal-title":"Dermatol. Surg."},{"issue":"12","key":"10.1016\/j.jtauto.2025.100331_bib163","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1111\/jocd.16525","article-title":"Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: a double\u2010blind randomized controlled trial","volume":"23","author":"Feily","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"issue":"11","key":"10.1016\/j.jtauto.2025.100331_bib164","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/ijd.15188","article-title":"Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial","volume":"59","author":"Gunaabalaji","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/DSS.0000000000001641","article-title":"Laser ablation of the recipient area with platelet-rich plasma\u2013enriched epidermal suspension transplant in vitiligo surgery: a pilot study","volume":"45","author":"Garg","year":"2019","journal-title":"Dermatol. Surg."},{"issue":"4","key":"10.1016\/j.jtauto.2025.100331_bib166","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jocd.13103","article-title":"Evaluation of combined excimer laser and platelet\u2010rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study","volume":"19","author":"Khattab","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.jtauto.2025.100331_bib167","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21608\/fumj.2019.60416","article-title":"Vitamin D and platelet rich plasma (PRP) in the treatment of vitiligo","volume":"3","author":"Abd El Raheem","year":"2019","journal-title":"Fayoum University Medical Journal"},{"key":"10.1016\/j.jtauto.2025.100331_bib168","series-title":"Efficacy of Platelet Rich Plasma Combined with Narrow Band UVB in the Treatment of Vitiligo","author":"Aslam","year":"2024"},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib169","first-page":"9854","article-title":"Efficacy of platelet rich plasma after skin needling in the treatment of vitiligo","volume":"8","author":"Abdelaty","year":"2021","journal-title":"Br. J. Res."},{"issue":"5","key":"10.1016\/j.jtauto.2025.100331_bib170","first-page":"1","article-title":"Treatment of vitiligo by PRP and umbilical cord blood: a prospective study in 120 cases","volume":"18","author":"Saify","year":"2019","journal-title":"IOSR J. Dent. Med. Sci."},{"key":"10.1016\/j.jtauto.2025.100331_bib171","series-title":"Effect of Platelet-Rich Plasma in Vitiligo: a Single-Arm Prospective Study","author":"Barnwal","year":"2025"},{"issue":"2","key":"10.1016\/j.jtauto.2025.100331_bib172","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/jewd.jewd_1_23","article-title":"Platelet-rich plasma versus microneedling effects in NB-UVB non-responder vitiligo patients","volume":"20","author":"Khalil","year":"2023","journal-title":"J. Egypt. Women\u2019s Dermatol. Soc"},{"issue":"9","key":"10.1016\/j.jtauto.2025.100331_bib173","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/medicina57090904","article-title":"Pilot study on the use of the \u201cmonocyte-rich\u201d platelet-rich plasma in combination with 1927 nm fractional and 308 nm excimer lasers for the treatment of vitiligo","volume":"57","author":"Mercuri","year":"2021","journal-title":"Medicina"}],"updated-by":[{"DOI":"10.1016\/j.jtauto.2025.100335","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000}},{"DOI":"10.1016\/j.jtauto.2025.100335","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:28:43Z","timestamp":1765358923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"alternative-id":["S2589909025000668"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100331","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging cell-based and cell-free therapeutic strategies for vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100331"}}